New rabies vaccine study shows promise for At-Risk adults
NCT ID NCT01044199
First seen May 18, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study tested a rabies vaccine given under the skin (intradermally) in 130 adults at risk of rabies exposure, such as lab workers and veterinarians. The goal was to see if the vaccine triggers a strong immune response and is safe. Results showed most participants developed protective antibodies with no major safety concerns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CDC Occupational Clinic
Atlanta, Georgia, 30333, United States
Conditions
Explore the condition pages connected to this study.